Asthma trials in Spain

In Spain 47 Also abroad 500

47 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Where
Alcorcón, Badalona, Barcelona, Esplugues de Llobregat, Girona, Granada, Logroño, Lugo, Madrid, Palma, Pamplona, Pozuelo de Alarcón, Santander, Sevilla, Valencia, Zaragoza
Age
12 years and over
People
456 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Barcelona, Esplugues de Llobregat, Jerez de la Frontera, Madrid, Sabadell, Santiago de Compostela, Valencia
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)
Where
Badalona, Barcelona, Huelva, Leganés, L'hospitalet De Llobregat, Málaga, Mataro, Peralada, Pontevedra, Santiago de Compostela, Sevilla, Valencia, Zaragoza
People
80 worldwide
Run by
Generate Biomedicines Inc.
See details and how to join2025-524040-35-00 · EU 2025-524040-35-00
Phase 3Taking people
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
Where
Badalona, Barcelona, Esplugues de Llobregat, Sabadell, Santiago de Compostela, Sevilla
Age
Up to 17 years
People
68 worldwide
Run by
Novartis Pharma AG
See details and how to join2022-502365-26-00 · EU 2022-502365-26-00
Phase 4Taking people
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Where
Badalona, Barcelona, Benalmádena, Madrid, Marbella, Sevilla, Zaragoza
Age
18 years and over
People
644 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00
Phase 3Taking people
Clinical trial to assess the efficacy and safety of a vaccine for dust mite and Lepidoglyphus destructor allergy.
Where
A Coruña, Alicante, Barcelona, Burela, Cadiz, Córdoba, Ferrol, Lugo, Ourense, Plasencia, Pontevedra, Sant Joan d'Alacant, Sevilla
People
120
Run by
Inmunotek S.L.
See details and how to join2025-522771-28-00 · EU 2025-522771-28-00
Phase 3Taking people
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of rhinitis/rhinoconjunctivitis in patients allergic to house dust mites.
Where
Alicante, Badajoz, Barcelona, Cadiz, Elche, Ibiza, Las Palmas de Gran Canaria, Lorca, Malaga, Málaga, Valencia, Vigo
People
250 worldwide
Run by
Inmunotek S.L.
See details and how to join2023-508548-23-00 · EU 2023-508548-23-00
Phase 3Taking people
Grass Immunotherapy for Rhinitis and Asthma (GIRA)
Where
Albacete, Alcorcón, Aranjuez, Ávila, Badajoz, Barcelona, Castello De La Plana, Cuenca, Elche, Fuenlabrada, Girona, Guadalajara, Leganés, Lleida, Llíria, Madrid, Majadahonda, Málaga, Manresa, Ourense, Pamplona, Plasencia, Pontevedra, Salamanca, Sevilla, Talavera De La Reina, Terrassa, Valencia, Valladolid, Vic, Zaragoza
People
324 worldwide
Run by
LETI Pharma S.L.U.
See details and how to join2025-521736-10-00 · EU 2025-521736-10-00
Phase 3Taking people
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of rhinitis/rhinoconjunctivitis in patients allergic to house dust mites.
Where
Alicante, Esplugues De Llobregat, La Laguna, Málaga, Melilla, Sant Joan d'Alacant, Sevilla, Terrassa, Villarreal
People
250 worldwide
Run by
Inmunotek S.L.
See details and how to join2023-508547-51-00 · EU 2023-508547-51-00
Phase 3Taking people
Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES)
Where
Albacete, Alcorcón, Almería, Aranjuez, Ávila, Badajoz, Barcelona, Castello De La Plana, Córdoba, Cuenca, Elche, Fuenlabrada, Girona, Granada, Guadalajara, Leganés, Lleida, Madrid, Majadahonda, Málaga, Móstoles, Murcia, Pamplona, Plasencia, Salamanca, San Sebastián de los Reyes, Sevilla, Talavera De La Reina, Terrassa, Valencia, Valladolid, Vic
People
343 worldwide
Run by
LETI Pharma S.L.U.
See details and how to join2025-521709-42-00 · EU 2025-521709-42-00
Phase 3Taking people
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Where
Barcelona, Benalmádena, L'hospitalet De Llobregat, Madrid, Palma, Santander, Valencia
Age
18 years and over
People
150 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00
No phaseTaking people
DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
Where
Seville
Age
18 years and over
People
280
Run by
Adhera Health, Inc.
See details and how to joinNCT07638345
No phaseNot yet taking people in Spain
Reference Equations and Normative Data for Isometric Quadriceps and Handgrip Muscles STrength in Southern European Populations - RESTart: a Multicentre Study
Where
Alcalá de Henares
Age
18 years to 89 years
People
2,815
Run by
University of Alcala
See details and how to joinNCT07628530
No phaseTaking people
EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
Where
Valencia
Age
12 years to 16 years
People
600
Run by
University of Valencia
See details and how to joinNCT07212530
No phaseTaking people
Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry
Where
A Coruña, Badalona, Barcelona, Madrid, Pamplona, Santiago de Compostela
Age
18 years to 80 years
People
1,200
Run by
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT06163807
No phaseTaking people
Oscillometry and Machine Learning Approaches
Where
Barcelona
Age
18 years to 99 years
People
50
Run by
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
See details and how to joinNCT07447596
Phase 3Taking people
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Where
Alicante, Benidorm
Age
12 years to 65 years
People
736 worldwide
Run by
Inmunotek S.L.
See details and how to joinNCT07348302
No phaseNot yet taking people in Spain
Pilot Study for the Application of Low Power External Bioelectronic Devices in the Diagnosis of Bronchial Asthma.
Where
Seville
Age
18 years to 65 years
People
50
Run by
Acurable Ltd.
See details and how to joinNCT06836375
Phase 3Taking people
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Where
Algeciras (Cádiz), Alicante, Badajoz, Barcelona, Cartagena, Córdoba, Lugo, Málaga, Melilla, Puerto de Santa María (Cádiz), Sagunto, Santander, Santiago de Compostela, Sevilla, Torrevieja, Valencia, Vigo, Clínica Privada en Murcia
Age
12 years to 65 years
People
150
Run by
Inmunotek S.L.
See details and how to joinNCT04435990 · EU 2024-514090-21-00
Phase 3Taking people
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Where
Ávila, Burgos, Collado Villalba, Cuenca, Madrid, Murcia, Pozuelo de Alarcón, Salamanca, Segovia, Torrelodones, Valladolid
Age
12 years to 65 years
People
180
Run by
Inmunotek S.L.
See details and how to joinNCT04898283 · EU 2024-514524-16-00
Phase 3Taking people
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Where
Ávila, Badajoz, Barcelona, Ciudad Real, Córdoba, Granada, Jaén, Lleida, Madrid, Málaga, Murcia, Palencia, Parla, Sevilla, Tarancón (Cuenca), Tres Cantos (Madrid), Valdemoro (Madrid), Valladolid
Age
12 years to 65 years
People
180
Run by
Inmunotek S.L.
See details and how to joinNCT04891237 · EU 2024-514525-34-00
Phase 4Not yet taking people in Spain
Omalizumab's dose reduction or increase in the frequency of administration in patients who suffer from allergic severe asthma
Where
Barcelona
Age
18 years and over
People
110
Run by
Consorci Mar Parc De Salut De Barcelona
See details and how to join2025-520782-48-00 · EU 2025-520782-48-00